AI assistant
Sending…
SELLAS Life Sciences Group, Inc. — Director's Dealing 2010
Jul 2, 2010
33651_dirs_2010-07-02_05a55fae-5d1d-4b06-ae08-32ba9db43489.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RXI PHARMACEUTICALS CORP (RXii)
CIK: 0001390478
Period of Report: 2010-06-30
Reporting Person: CYTRX CORP (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2010-06-30 | Common Stock | S | 2000000 | $2.55 | Disposed | 3093881 | Direct |
More from SELLAS Life Sciences Group, Inc.
Regulatory Filings
2026
May 12
Interim / Quarterly Report
2026
May 12
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 20
Major Shareholding Notification
2026
Jan 30
Director's Dealing
2026
Jan 9
Director's Dealing
2026
Jan 9
Director's Dealing
2026
Jan 9
Director's Dealing
2026
Jan 9
Director's Dealing
2026
Jan 9